Google DeepMind releases AlphaFold 3
It predict the structures and interactions of nearly all of life’s molecules with state-of-the-art accuracy including proteins, DNA and RNA 🤯
I’m so here for this
I am pleased to announce my appointment as President and CEO of @NYSCF. I am inspired to continue to advance the field of stem cell research and honored to lead this tremendous organization in its next chapter. https://t.co/P7dDQGjear #stemcells#precisionmedicine#biomedicine
👩🎓👩🔬 As we celebrate today the International Day of Women (and Girls) in Science - we are Proud of Dr. Rotem Shemesh - PhD @E_Segal_Lab 2016 for being elected as @biofoodeng alumni who make a difference.
#womensinscience
#TranscriptionAndTranslation#TXTL News: FDA Approves New CRISPR Gene-Editing Treatment
Casgevy’s novel CRISPR gene-editing technology modifies patients’ blood cells and transplant them back into their bone marrow, triggering increases in hemoglobin. https://t.co/MyexrzeyVV
"One of the advantages of deep learning in AI is the capability to work simultaneously with multiple types of data from different sources to discover new predictions... " - Marcial García-Rojo, MD, Ph.D.
See the full article from OpCo @LeicaBio . https://t.co/2QFW8pvNDu
How to design binders to any small molecule ligands, flexible or polar? How to turn binders turned to sensors without complicated engineering? We solved these 2 problems with a single method, binder and sensor design through shape complementary pseudocycles.
Dr. Joe DeRisi, professor at @UCSFMedicine and
@czbiohub, who specializes in solving medical mysteries. He joins us to discuss his fascinating work solving some of the most vexing medical mysteries.
https://t.co/alnixwmZWZ
We’ve teamed up with @Genentech to unlock the full potential of lipid nanoparticles (LNPs) in drug delivery. 🚀🧬 With LNPs, we could see groundbreaking advances in vaccines for infectious diseases and #cancer therapies. #biotech#health
https://t.co/uH5NbkGD7O
@SikkemaLisa Really happy that our Human Lung Cell Atlas is out @NatureMedicine! Big collaborative effort, and very useful for a broader understanding of cellular variation in lung across people, disease,
labs & technologies. Big thanks to all partners @humancellatlas!
https://t.co/7H5PbQASI3
We are excited to announce a new computational tool, drug2cell, published in @nature. This tool can provide insights into the precise cellular targets of drugs.
Want to know all about it? Keep reading!
#genomictool#sangerinnovation
I now end every ChatGPT prompt with "Talk to me like I'm a scientist who knows the jargon. Be casual and concise".
IT'S AMAZING. If only everyone could be prompted to talk this way.
I now end every ChatGPT prompt with "Talk to me like I'm a scientist who knows the jargon. Be casual and concise".
IT'S AMAZING. If only everyone could be prompted to talk this way.
Biotechs are rushing into #AI drug design - it’s a noisy field. By being the first to create de novo versions of all three heavy chain CDRs, Imad Ajjawi says Absci is proving it’s at the forefront, giving our partners unique confidence.
https://t.co/xTvR4qdNdP